Safety and Efficacy of Drug-Coated Balloons in Patients with Acute Coronary Syndromes and Vulnerable Plaque

BACKGROUND: Percutaneous coronary intervention (PCI) is the main treatment option for acute coronary syndromes (ACS) often related to the progression and rupture of vulnerable plaques. While drug-eluting stents (DES) are now routinely used in PCI, drug-coated balloons (DCB) are a new strategy to PCI...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Yu-Bin, Liu, Heng-Dao, Xing, Jun-Hui, Chen, Bo-Wen, Zhao, Yan-Yan, Gu, He-Ping, Tao, Hai-Long
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2022
Materias:
Original Manuscript
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9537494/
https://www.ncbi.nlm.nih.gov/pubmed/36198017
http://dx.doi.org/10.1177/10760296221130063

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9537494/
https://www.ncbi.nlm.nih.gov/pubmed/36198017
http://dx.doi.org/10.1177/10760296221130063

Ejemplares similares